Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer

estrogen receptor-negative breast cancer, her2-negative breast cancer, hereditary breast/ovarian cancer - brca1, hereditary breast/ovarian cancer - brca2, male breast cancer, progesterone receptor-negative breast cancer, recurrent breast cancer, stage iv breast cancer, triple-negative breast cancer, interventional, phase1